Vir Biotechnology (VIR) Other Operating Expenses (2019 - 2025)

Vir Biotechnology has reported Other Operating Expenses for 6 years, with the latest figure at $26000.0 in Q4 2025.

• Quarterly Other Operating Expenses fell 96.2% year-over-year to $26000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $26000.0 (down 96.69% YoY) and the FY2025 annual result came in at $26000.0, down 96.92% from the prior year.
• Other Operating Expenses advanced to $26000.0 in Q4 2025 per VIR's latest filing, from -$11000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $90.1 million in Q1 2022 and troughed at -$11000.0 in Q3 2025.
• A 5-year average of $12.0 million and a median of $741000.0 in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Other Operating Expenses surged 2340.65% in 2022, then plunged 122.0% in 2025.
• Over 5 years, Other Operating Expenses stood at $56.9 million in 2021, then sank by 89.46% to $6.0 million in 2022, then slumped by 86.69% to $798000.0 in 2023, then decreased by 14.29% to $684000.0 in 2024, then sank by 96.2% to $26000.0 in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $26000.0, -$11000.0, and $11000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.